NDCN welcomes ocular oncologist
19 November 2018
Bertil Damato will oversee the provision of clinical care to patients with an ocular tumour and develop a research group to focus on ocular melanoma and other eye tumours.
Gene therapy breakthrough in treating a rare form of blindness
8 October 2018
The positive results of the world’s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in this week’s edition of Nature Medicine.
Digital insomnia medicine rolled out as major study links sleep to better health
30 September 2018
Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.
First human test of robotic eye surgery a success
18 June 2018
The first trial of robot-assisted eye surgery in patients has shown the technique to be both safe and effective.
Sleep scientists collaborate with nightshift workers on art project
12 March 2018
Researchers at the Sleep and Circadian Neuroscience Institute (SCNi) have been working with visual artist Martin Kohout to reveal the stories of the night-shift workers who keep London running.
Gene therapy shows promise for reversing blindness
3 October 2017
In a laboratory study in Oxford, researchers have shown how it might be possible to reverse blindness using gene therapy to reprogram cells at the back of the eye to become light sensitive.
New trial for blindness rewrites the genetic code
20 March 2017
Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people.
New spinout addresses sleep and circadian rhythm disruption
3 January 2017
Circadian Therapeutics has been established to identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
Second phase of gene therapy trial for blindness under way
10 November 2016
The trial involves injecting a virus into the eye to deliver billions of healthy genes to replace a key missing gene for choroideremia sufferers.
World first for robot eye operation
13 September 2016
University of Oxford surgeons at Oxford's John Radcliffe Hospital have performed the world's first operation inside the eye using a robot.
Spinout develops smart glasses
9 August 2016
Clinical Neurology Ophthalmology Research
A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
Lighting colour affects sleep and wakefulness
15 June 2016
Our researchers have shown how different colours of light could affect our ability to sleep.
Gene therapy shows long-term benefit for treating blindness
29 April 2016
Pioneering gene therapy has restored some vision to John Radcliffe Hospital patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.
Public missing out on a night’s worth of sleep every week
31 March 2016
Experts call for introduction of sleep guidelines in new report
Blind woman’s joy as she is able to read the time thanks to 'bionic eye'
5 January 2016
A patient who is the first in the UK to receive the world’s most advanced 'bionic eye' has been able to read the time for the first time in more than five years.
Why sleep could be the key to tackling mental illness
10 November 2015
Professor Russell Foster writes about circadian rhythm and health on the online news platform 'The Conversation'
£23 million boost for Oxford spinout company
9 November 2015
More money comes in to further work on gene therapy for choroideremia